Pelvic Congestion Syndrome Post Tubal Ligation Versus Salpingectomy Performed During Caesarean Section
NCT ID: NCT06509425
Last Updated: 2024-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
64 participants
INTERVENTIONAL
2024-05-21
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies revealing bilateral salpingectomy has an added benefit of primary prevention of ovarian cancer has encouraged surgeons to perform bilateral salpingectomy rather than tubal ligation as a risk reducing surgery owing to the acceptance of fallopian tubes as the origin of high grade serous ovarian cancer.
Another aspect to take into consideration is the post tubal ligation syndrome as it severely affects the quality of life. Diagnosis is based on clinical picture, imaging, and exclusion of other causes of chronic pelvic pain. Women experience dysmenorrhea, dyspareunia, menstrual irregularities, and pelvic pain. The gold standard is venography; however, the first choice for initial evaluation is duplex ultrasound.
In this study, we assess impact of bilateral salpingectomy versus tubal ligation in terms of pelvic congestion by participant's symptoms and ultrasound findings
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery
NCT06273683
Salpingectomy During Cesarean Section
NCT02880423
Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery
NCT03135431
Driving Factors of Decision Making for Prophylactic Salpingectomy Versus Tubal Ligation at the Time of Cesarean Section
NCT03830502
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
NCT03028623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Informed written consent will be taken from all the participants before enrollment in the study.
Randomization will be done at a 1:1 ratio to bilateral salpingectomy or bilateral tubal ligation by a computer-generated scheme. Sequentially numbered sealed opaque envelopes will be prepared, each containing patient allocated procedure. It will be revealed to the case surgeon.
1\) Surgical Intervention: Caesarean section and tubal sterilization will be performed by resident on duty.
Identification of the fimbriated end of the Fallopian tube. It will be grasped by a Babcock or Allis forceps.
Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.
Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.
Hemostasis will be ensured at the incised edges. Participants undergoing salpingectomy will have their fallopian tubes sent for pathological examination to confirm transection and exclude malignancies.
2\) Postoperative assessment: Follow up visit after ten weeks.
1. History:
The participant is asked about these symptoms:
* Menstrual irregularities
* Dull, noncyclical throbbing pelvic pain (unilateral or bilateral), worsened with long periods of standing or walking and punctuated by intermittent sharp pain.
2. Sonographic evaluation:
It will be done by the same investigator (Assistant Lecturer at Radiology department, Ain Shams University).
Machine used:
Samsung ultrasound machine with Transvaginal probe 5-7 Megahertz
All participants will be asked to empty their urinary bladder and will be placed in lithotomy position with adequate covering of the participants for transvaginal position. The assessment will detect:
1. Presence of pelvic varicocele. (tortuous and dilated veins that are greater than 6 mm in diameter around the ovary and uterus)
2. Maximal diameter of the pelvic venous plexus.
3. Presence of crossing veins in the myometrium.
4. Change of the duplex waveform during Valsalva's maneuver in both ovarian and internal iliac veins.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants undergoing caesarean section and salpingectomy.
salpingectomy during caesarean section
Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.
Participants undergoing caesarean section and tubal ligation
tubal ligation during caesarean section
Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
salpingectomy during caesarean section
Salpingectomy will be done by clamping, division and ligation using adsorbable suture material (2-0 Vicryl) and excising the tube till it's isthmic part by scissors.
tubal ligation during caesarean section
Tubal ligation will be done by Parkland technique. An opening is made in an avascular section of the mesosalpinx by electrocautery. Two absorbable suture ties (2-0 Vicryl) are passed through the opening and used to ligate the proximal and distal ends of the segment (at least 2 cm) which will get excised by scissors.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 30 years or older
Exclusion Criteria
* Previous history of oophorectomy (changes in blood flow)
* Congenital anomalies or malformations in fallopian tubes or ovaries. (affection of normal anatomy of pelvic blood vessels)
* Women diagnosed with pelvic congestion. (Known cause for pelvic congestion other than tubal sterilization)
* High likelihood of lost to follow up.
* Inability to provide good data.
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity Hospitals
Cairo, Abaseya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
maternity H
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS 296/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.